Mark Morrison has been a consultant with the firm for the past six months. Tue, 18 May 2021 Mark Morrison Mark Morrison has been appointed chief commercial officer at New Zealand-licenced medicinal cannabis company Helius Therapeutics. For six months prior to the appointment, he was a consultant at Helius where he developed the company’s commercial strategy. The announcement of CCO completes the executive leadership team at the Auckland Helius headquarters. With significant experience in Australia, the US and New Zealand, Morrison has worked in the pharmaceutical, animal health, and FMCG industries for more than 25 years. He has held senior global marketing, strategic planning, new product and business development positions, and has consulted in the medicinal cannabis sector since 2018.